|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abstract
Estrogen induces proliferation of uterine epithelium
through a paracrine action of estrogen receptor
(ER
) in the underlying stroma. In ovariectomized
mice primed with progesterone, estrogen stimulates
proliferation in both the epithelium and the stroma.
We set out to test whether a paracrine mode of action
is involved in estrogen-induced proliferation of the
uterine stroma. Epithelial and mesenchymal tissues
derived from uteri of neonatal ER
null mice
(ER
KO) or wildtype mice were separated and
recombined in all four possible configurations
(ER
+ or ER
-
epithelium with ER
+or
ER
- mesenchyme) and grafted into
female athymic mice. After five weeks, hosts were
ovariectomized, challenged with hormone treatment, and
cellular proliferation was monitored by thymidine
autoradiography. Results showed that, although the full
response of the epithelium was dependent upon an
ER
-positive mesenchyme, stromal cell
proliferation was independent of tissue ER
. This
latter observation suggests that the response of the
stroma was due to a systemic factor induced in the
ER
-positive hosts. To test this possibility,
pieces of whole uterus from neonatal wildtype or
ER
KO mice were grafted into syngeneic wildtype or
ER
KO hosts. In these whole-uterus grafts,
estradiol stimulated ER
KO uterine stroma when
they were grown in wildtype hosts but not when grown in
ER
KO hosts. The epithelium of ER
KO grafts
did not respond to estrogen, regardless of the host
phenotype. These observations suggest that treatment of
progesterone-primed mice with estradiol stimulates
production of a systemic factor that is capable of
inducing uterine stromal cell proliferation and that this
systemic factor is produced by an ER
-dependent
mechanism.
Key words:
Estradiol receptor
Growth factors
Progesterone
Uterus
This article has been cited by other articles:
![]() |
Y. Liang, C. Besch-Williford, R. A. Brekken, and S. M. Hyder Progestin-Dependent Progression of Human Breast Tumor Xenografts: A Novel Model for Evaluating Antitumor Therapeutics Cancer Res., October 15, 2007; 67(20): 9929 - 9936. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Marriott, K. R. McGann-Gramling, B. Hauss-Wegrzyniak, L. C. Sheldahl, R. A. Shapiro, D. M. Dorsa, and G. L. Wenk Brain Infusion of Lipopolysaccharide Increases Uterine Growth as a Function of Estrogen Replacement Regimen: Suppression of Uterine Estrogen Receptor-{alpha} by Constant, But Not Pulsed, Estrogen Replacement Endocrinology, January 1, 2007; 148(1): 232 - 240. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |